Novel 64Cu-Labeled NOTA-Conjugated Lactam-Cyclized Alpha-Melanocyte-Stimulating Hormone Peptides with Enhanced Tumor to Kidney Uptake Ratios

Cancer Statistics, 2021

(2021) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Novel [99mTc]-Tricarbonyl-NOTA-Conjugated Lactam-Cyclized Alpha-MSH Peptide with Enhanced Melanoma Uptake and Reduced Renal Uptake

(2020) Zheng Qiao et al.   MOLECULAR PHARMACEUTICS

Evaluation of a Novel Pb-203-Labeled Lactam-Cyclized Alpha-Melanocyte-Stimulating Hormone Peptide for Melanoma Targeting

(2019) Jianquan Yang et al.   MOLECULAR PHARMACEUTICS

Immunotherapy of melanoma: facts and hopes

(2019) Sarah A Weiss et al.   CLINICAL CANCER RESEARCH

Melanoma-Targeting Property of Y-90-Labeled Lactam-Cyclized α-Melanocyte-Stimulating Hormone Peptide

(2019) Jingli Xu et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

68Ga-DOTA-GGNle-CycMSHhex targets the melanocortin-1 receptor for melanoma imaging

(2018) Jianquan Yang et al.   Science Translational Medicine

Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab

(2014) Suzanne L. Topalian et al.   JOURNAL OF CLINICAL ONCOLOGY

Introduction of an 8-Aminooctanoic Acid Linker Enhances Uptake of 99mTc-Labeled Lactam Bridge-Cyclized  -MSH Peptide in Melanoma

(2014) H. Guo et al.   JOURNAL OF NUCLEAR MEDICINE

PET Imaging of Very Late Antigen-4 in Melanoma: Comparison of 68Ga- and 64Cu-Labeled NODAGA and CB-TE1A1P-LLP2A Conjugates

(2014) W. Beaino et al.   JOURNAL OF NUCLEAR MEDICINE

Melanoma targeting property of a Lu-177-labeled lactam bridge-cyclized alpha-MSH peptide

(2013) Haixun Guo et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Design and Evaluation of New Tc-99m-Labeled Lactam Bridge-Cyclized Alpha-MSH Peptides for Melanoma Imaging

(2013) Haixun Guo et al.   MOLECULAR PHARMACEUTICS

Gallium-67-Labeled Lactam Bridge-Cyclized Alpha-MSH Peptides with Enhanced Melanoma Uptake and Reduced Renal Uptake

(2012) Haixun Guo et al.   BIOCONJUGATE CHEMISTRY

Cu-64-Labeled Lactam Bridge-Cyclized α-MSH Peptides for PET Imaging of Melanoma

(2012) Haixun Guo et al.   MOLECULAR PHARMACEUTICS

Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib

(2012) Jeffrey A. Sosman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of two cross-bridged macrocyclic chelators for the evaluation of 64Cu-labeled-LLP2A, a peptidomimetic ligand targeting VLA-4-positive tumors

(2012) Majiong Jiang et al.   NUCLEAR MEDICINE AND BIOLOGY

Effects of the Amino Acid Linkers on the Melanoma-Targeting and Pharmacokinetic Properties of 111In-Labeled Lactam Bridge-Cyclized  -MSH Peptides

(2011) H. Guo et al.   JOURNAL OF NUCLEAR MEDICINE

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

(2011) Paul B. Chapman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Reduction of the Ring Size of Radiolabeled Lactam Bridge-Cyclized  -MSH Peptide, Resulting in Enhanced Melanoma Uptake

(2010) H. Guo et al.   JOURNAL OF NUCLEAR MEDICINE

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phase I/II Study of Ipilimumab for Patients With Metastatic Melanoma

(2008) Jeffrey S. Weber et al.   JOURNAL OF CLINICAL ONCOLOGY